{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:37:40Z","timestamp":1790933860517,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Anemia in patients with CKD is highly related to impaired erythropoietin (EPO) response, the timing and determinants of which remain unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>This study measured EPO levels and studied their relation to GFR measured by 51Cr-EDTA renal clearance (mGFR) in 336 all-stage CKD patients not receiving any erythropoiesis-stimulating agent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In patients with anemia defined by World Health Organization criteria (hemoglobin [Hb] &lt;13 g\/dl in men and 12 g\/dl in women), EPO response to Hb level varied by mGFR level. EPO and Hb levels were negatively correlated (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      =\u22120.22,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.04) when mGFR was &gt;30 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      , whereas they were not correlated when mGFR was &lt;30 (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      =0.09,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.3;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for interaction=0.01). In patients with anemia, the ratio of observed EPO to the level predicted by the equation for their Hb level decreased from 0.72 (interquartile range, 0.57\u20130.95) for mGFR \u226560 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      to 0.36 (interquartile range, 0.16\u20130.69) for mGFR &lt;15. Obesity, diabetes with nephropathy other than diabetic glomerulopathy, absolute iron deficiency, and high C-reactive protein concentrations were associated with increased EPO levels, independent of Hb and mGFR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Anemia in CKD is marked by an early relative EPO deficiency, but several factors besides Hb may persistently stimulate EPO synthesis. Although EPO deficiency is likely the main determinant of anemia in patients with advanced CKD, the presence of anemia in those with mGFR &gt;30 ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      calls for other explanatory factors.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.04690511","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T00:43:50Z","timestamp":1321577030000},"page":"35-42","source":"Crossref","is-referenced-by-count":62,"title":["Timing and Determinants of Erythropoietin Deficiency in Chronic Kidney Disease"],"prefix":"10.2215","volume":"7","author":[{"given":"Lucile","family":"Mercadal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Haymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vrtovsnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Froissart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230811","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1073\/pnas.68.4.697","article-title":"Purification of erythropoietin.","volume":"68","author":"Goldwasser","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"R2-9-20230811","first-page":"849","article-title":"Murine erythropoietin gene: Cloning, expression, and human gene homology.","volume":"6","author":"Shoemaker","year":"1986","journal-title":"Mol Cell Biol"},{"key":"R3-9-20230811","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia.","volume":"355","author":"Dr\u00fceke","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-9-20230811","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease.","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"R5-9-20230811","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"R6-9-20230811","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ki.2010.233","article-title":"Hypothesis: An erythropoietin honeymoon phase exists.","volume":"78","author":"Fishbane","year":"2010","journal-title":"Kidney Int"},{"key":"R7-9-20230811","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJM199105093241907","article-title":"Erythropoietin.","volume":"324","author":"Erslev","year":"1991","journal-title":"N Engl J Med"},{"key":"R8-9-20230811","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood.V81.4.1067.1067","article-title":"Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.","volume":"81","author":"Beguin","year":"1993","journal-title":"Blood"},{"key":"R9-9-20230811","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1523-1755.2004.00880.x","article-title":"Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia.","volume":"66","author":"Fehr","year":"2004","journal-title":"Kidney Int"},{"key":"R10-9-20230811","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ki.1987.129","article-title":"Erythropoietin-hematocrit feedback circuit in the anemia of end-stage renal disease.","volume":"31","author":"Walle","year":"1987","journal-title":"Kidney Int"},{"key":"R11-9-20230811","doi-asserted-by":"crossref","first-page":"M880","DOI":"10.1097\/00002480-199407000-00122","article-title":"Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved.","volume":"40","author":"Ross","year":"1994","journal-title":"ASAIO J"},{"key":"R12-9-20230811","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.2007111181","article-title":"The effect of altitude on dosing and response to erythropoietin in ESRD.","volume":"19","author":"Brookhart","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R13-9-20230811","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.1984.36","article-title":"Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency.","volume":"25","author":"McGonigle","year":"1984","journal-title":"Kidney Int"},{"key":"R14-9-20230811","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.V54.4.877.877","article-title":"Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function.","volume":"54","author":"Radtke","year":"1979","journal-title":"Blood"},{"key":"R15-9-20230811","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications.","volume":"20","author":"Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R16-9-20230811","first-page":"443","article-title":"A clinical evaluation of serum ferritin as an index of iron stores. 1974.","volume":"8","author":"Lipschitz","year":"1992","journal-title":"Nutrition"},{"key":"R17-9-20230811","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","article-title":"Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.","volume":"16","author":"Froissart","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R18-9-20230811","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"R19-9-20230811","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCULATIONAHA.108.844662","article-title":"Endogenous erythropoietin and outcome in heart failure.","volume":"121","author":"Belonje","year":"2010","journal-title":"Circulation"},{"key":"R20-9-20230811","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/eurheartj\/ehn205","article-title":"Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.","volume":"29","author":"van der Meer","year":"2008","journal-title":"Eur Heart J"},{"key":"R21-9-20230811","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehi388","article-title":"Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.","volume":"26","author":"Opasich","year":"2005","journal-title":"Eur Heart J"},{"key":"R22-9-20230811","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0022-3476(10)80002-2","article-title":"Comparison of the erythropoietin response in children with aplastic anemia, transient erythroblastopenia, and iron deficiency.","volume":"120","author":"Bray","year":"1992","journal-title":"J Pediatr"},{"key":"R23-9-20230811","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1532-5415.1993.tb06479.x","article-title":"Serum erythropoietin levels in elderly inpatients with anemia of chronic disorders and iron deficiency anemia.","volume":"41","author":"Joosten","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"R24-9-20230811","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2005-08-3364","article-title":"Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease.","volume":"107","author":"Theurl","year":"2006","journal-title":"Blood"},{"key":"R25-9-20230811","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000168696","article-title":"Influence of body iron stores on the serum erythropoietin concentration in hemodialyzed patients.","volume":"14","author":"Teruel","year":"1994","journal-title":"Am J Nephrol"},{"key":"R26-9-20230811","doi-asserted-by":"crossref","first-page":"750643","DOI":"10.1155\/2010\/750643","article-title":"Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias.","volume":"2010","author":"Nemeth","year":"2010","journal-title":"Adv Hematol"},{"key":"R27-9-20230811","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3324\/haematol.2009.013136","article-title":"Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.","volume":"95","author":"Ashby","year":"2010","journal-title":"Haematologica"},{"key":"R28-9-20230811","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ki.2010.217","article-title":"Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failure.","volume":"78","author":"Srai","year":"2010","journal-title":"Kidney Int"},{"key":"R29-9-20230811","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood-2009-10-251496","article-title":"Iron control of erythroid development by a novel aconitase-associated regulatory pathway.","volume":"116","author":"Bullock","year":"2010","journal-title":"Blood"},{"key":"R30-9-20230811","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1182\/blood-2010-04-281360","article-title":"Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis.","volume":"116","author":"Forejtnikov\u00e0","year":"2010","journal-title":"Blood"},{"key":"R31-9-20230811","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1038\/oby.2008.353","article-title":"Is obesity associated with anemia of chronic disease? A population-based study.","volume":"16","author":"Ausk","year":"2008","journal-title":"Obesity (Silver Spring"},{"key":"R32-9-20230811","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/oby.2009.319","article-title":"Elevated systemic hepcidin and iron depletion in obese premenopausal females.","volume":"18","author":"Tussing-Humphreys","year":"2010","journal-title":"Obesity (Silver Spring"},{"key":"R33-9-20230811","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/0003-4819-121-3-199408010-00004","article-title":"The anemia of primary autonomic failure and its reversal with recombinant erythropoietin.","volume":"121","author":"Biaggioni","year":"1994","journal-title":"Ann Intern Med"},{"key":"R34-9-20230811","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/diacare.24.3.495","article-title":"Anemia with erythropoietin deficiency occurs early in diabetic nephropathy.","volume":"24","author":"Bosman","year":"2001","journal-title":"Diabetes Care"},{"key":"R35-9-20230811","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2215\/CJN.00380111","article-title":"Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.","volume":"6","author":"Wagner","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R36-9-20230811","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.V79.8.1987.1987","article-title":"Effect of inflammatory cytokines on hypoxia-induced erythropoietin production.","volume":"79","author":"Faquin","year":"1992","journal-title":"Blood"},{"key":"R37-9-20230811","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1991.tb17252.x","article-title":"Interleukin-1 and tumor necrosis factor-alpha inhibit erythropoietin production in vitro.","volume":"628","author":"Fandrey","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"R38-9-20230811","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cyto.2010.03.020","article-title":"Erythropoietin-dependent endothelial proteins: Potential use against erythropoietin resistance.","volume":"51","author":"Congote","year":"2010","journal-title":"Cytokine"},{"key":"R39-9-20230811","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1182\/blood.V87.11.4824.bloodjournal87114824","article-title":"Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.","volume":"87","author":"Cazzola","year":"1996","journal-title":"Blood"},{"key":"R40-9-20230811","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood.V92.5.1793.417k23_1793_1798","article-title":"Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production.","volume":"92","author":"Corazza","year":"1998","journal-title":"Blood"},{"key":"R41-9-20230811","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1001\/jama.1989.03420210052015","article-title":"Serum immunoreactive erythropoietin in HIV-infected patients.","volume":"261","author":"Spivak","year":"1989","journal-title":"JAMA"},{"key":"R42-9-20230811","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1056\/NEJMoa1005109","article-title":"Erythropoietic response and outcomes in kidney disease and type 2 diabetes.","volume":"363","author":"Solomon","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201201000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:30Z","timestamp":1786369290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201201000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04690511","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}